Phase I study of autologous CD8+ and CD4+ transgenic T cells expressing high-affinity KRAS G12V mutation-specific T cell receptors (FH-A11KRASG12V-TCR) in patients with metastatic pancreatic, ...

HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML. This amendment, filed with the U.S. Food and Drug Administration (FDA), seeks ...

LONDON, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has filed an amendment to the clinical protocol for its ongoing Phase ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the proposal presented by Novartis Healthcare for protocol amendment ...

Methods and analysis We designed this protocol according to the Standard Protocol Items: Recommendations for Interventional Trials guidelines as a phase II, single-centred, single group and ...

Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia A single-blind, randomized, ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the results of a phase 3 clinical trial published Wednesday in the Journal of ...

Clinical trials of a new, minimally invasive treatment for degenerated spinal discs have produced impressive results, significantly reducing back pain severity and improving function. It could ...

Credit: Dejan Dundjerski / Shutterstock. German pharmaceutical company Boehringer Ingelheim has started the JADE Phase II clinical trial to evaluate BI 1584862 as a first-in-class oral treatment for ...

We plan to advance the clinical development of PER-001, with initiation of an adaptive Phase 2b trial in glaucoma in the second half of 2025 that we believe could serve as one of two pivotal studies ...

is struggling to carry out its mission of running clinical trials for the hardest-to-treat diseases amid growing disruptions from the Trump administration. Fewer patients are being treated ...